Galectin Therapeutics stock looks like a compelling swing long setup on the chart. The gambit is a bounce off its 200 day moving average support.
Author: Lance Jepsen
For ethical purposes, I try not to hold any position in any stock I profile on GuerillaStockTrading.com unless specifically stated in the article. Owner of GuerillaStockTrading.com. Seasoned entrepreneur, investor, and writer. I love God, family, country, stock trading, economics, and helping people learn how to trade. View all posts by Lance Jepsen